5-(3-bromobenzyl)thiazol-2-amine

ID: ALA4874873

Cas Number: 923737-16-0

PubChem CID: 16228106

Max Phase: Preclinical

Molecular Formula: C10H9BrN2S

Molecular Weight: 269.17

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncc(Cc2cccc(Br)c2)s1

Standard InChI:  InChI=1S/C10H9BrN2S/c11-8-3-1-2-7(4-8)5-9-6-13-10(12)14-9/h1-4,6H,5H2,(H2,12,13)

Standard InChI Key:  QGPGPGCUYYOGGE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
   31.0161   -3.1285    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.8374   -3.1285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0959   -2.3476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.4288   -1.8655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7659   -2.3476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9845   -2.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3733   -2.6467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3211   -3.7943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.5927   -2.3879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9860   -2.9383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1560   -3.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9423   -3.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5498   -3.4456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2047   -2.6858    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  5  6  1  0
  6  7  1  0
  2  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  7  1  0
 10 14  1  0
M  END

Alternative Forms

Associated Targets(Human)

KCNMA1 Tclin Calcium-activated potassium channel subunit alpha-1 (435 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 269.17Molecular Weight (Monoisotopic): 267.9670AlogP: 3.08#Rotatable Bonds: 2
Polar Surface Area: 38.91Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.31CX LogP: 3.48CX LogD: 3.48
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.91Np Likeness Score: -1.56

References

1. Qi XL, Jo H, Wang XY, Ji TT, Lin HX, Park CS, Cui YM..  (2021)  Synthesis and BK channel-opening activity of 2-amino-1,3-thiazole derivatives.,  43  [PMID:33964448] [10.1016/j.bmcl.2021.128083]
2. Valverde, M A MA and 8 more authors.  1999-09-17  Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit.  [PMID:10489376]
3. Gribkoff, V K VK and 29 more authors.  2001-04  Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.  [PMID:11283675]

Source